Top Tweets for #MITCEO

3 days ago

Excellent discussion last week at #MITCEO on “Existing Pipelines: Maintaining Clinical Progress.” Thanks to @LongwoodLeaders for convening a terrific group and fostering candid conversations on the realities of advancing pipelines in today’s biotech environment. Together with Peter Joyce (@GreyWolfTx), Mani Mohindru (@CardiffOnc), and Sabeen Mekan (@Zymeworks), we discussed translational science, portfolio prioritization, capital allocation, regulatory strategy, and the difficult decisions required to maintain momentum. One theme that resonated throughout was the importance of learning from setbacks and continuously moving between bench and bedside to maximize patient impact. Jennifer Michaelson (@CullinanOncology), who unfortunately could not join us on the day, provided valuable insights during our preparation discussions, particularly around biomarker-driven development and translational science. Thank you all for the engaging discussion and to @LongwoodLeaders for another outstanding meeting.

paulpetertak's tweet photo. Excellent discussion last week at #MITCEO on “Existing Pipelines: Maintaining Clinical Progress.”
Thanks to @LongwoodLeaders for convening a terrific group and fostering candid conversations on the realities of advancing pipelines in today’s biotech environment.
Together with Peter Joyce (@GreyWolfTx), Mani Mohindru (@CardiffOnc), and Sabeen Mekan (@Zymeworks), we discussed translational science, portfolio prioritization, capital allocation, regulatory strategy, and the difficult decisions required to maintain momentum. One theme that resonated throughout was the importance of learning from setbacks and continuously moving between bench and bedside to maximize patient impact.
Jennifer Michaelson (@CullinanOncology), who unfortunately could not join us on the day, provided valuable insights during our preparation discussions, particularly around biomarker-driven development and translational science.
Thank you all for the engaging discussion and to @LongwoodLeaders for another outstanding meeting.

501

Candel Therapeutics @CandelTx

14 days ago

Our CEO @paulpetertak will moderate the "Existing Pipelines: Maintaining Clinical Progress" panel at the @LongwoodLeaders MIT CEO forum, on June 16. https://t.co/G2lBpw1rtF #MITCEO #Biotech #Biopharma $CADL

CandelTx's tweet photo. Our CEO @paulpetertak will moderate the "Existing Pipelines: Maintaining Clinical Progress" panel at the
@LongwoodLeaders MIT CEO forum, on June 16.

https://t.co/G2lBpw1rtF

#MITCEO #Biotech #Biopharma $CADL https://t.co/4tzGaphUi6

955

Dr. Paul Peter Tak

@paulpetertak

about 1 month ago

Excited to moderate the panel “Existing Pipelines: Maintaining Clinical Progress” at #MITCEO, hosted at the Koch Institute at MIT on June 15–16. Looking forward to an engaging discussion with outstanding leaders driving innovation across oncology and translational medicine: Peter Joyce, Jennifer Michaelson, and Mani Mohindru. One of the most important questions in biotech today: how do we keep momentum, advance promising programs, and continue delivering for patients while navigating an increasingly complex environment? See you in Cambridge! @LongwoodLeaders

paulpetertak's tweet photo. Excited to moderate the panel “Existing Pipelines: Maintaining Clinical Progress” at #MITCEO, hosted at the Koch Institute at MIT on June 15–16.
Looking forward to an engaging discussion with outstanding leaders driving innovation across oncology and translational medicine: Peter Joyce, Jennifer Michaelson, and Mani Mohindru.
One of the most important questions in biotech today: how do we keep momentum, advance promising programs, and continue delivering for patients while navigating an increasingly complex environment?
See you in Cambridge!
@LongwoodLeaders

518

Ovid Therapeutics

@OvidRx

about 1 year ago

Ovid CEO Jeremy Levin will moderate “Supporting Research at the Intersection of Policy and Science” at #MITCEO later today. He’ll lead a timely discussion with Congressman Jake Auchincloss, former FDA Commissioner Dr. Robert Califf, and MIT President Emerita Dr. Susan Hockfield. @LongwoodLeaders @LongwoodFund

OvidRx's tweet photo. Ovid CEO Jeremy Levin will moderate “Supporting Research at the Intersection of Policy and Science” at #MITCEO later today.

He’ll lead a timely discussion with Congressman Jake Auchincloss, former FDA Commissioner Dr. Robert Califf, and MIT President Emerita Dr. Susan Hockfield.

@LongwoodLeaders @LongwoodFund

Longwood Healthcare Leaders @LongwoodLeaders

about 1 year ago

It has been our honor to host #biotech and #pharma leaders during a crucial time in the industry. The commitment demonstrated to convening during this time depicts the sectors dedication to patient care and innovation We look forward to continuing these conversations at #MITCEO

LongwoodLeaders's tweet photo. It has been our honor to host #biotech and #pharma leaders during a crucial time in the industry. The commitment demonstrated to convening during this time depicts the sectors dedication to patient care and innovation We look forward to continuing these conversations at #MITCEO https://t.co/VtHk2wuATP

290

Top Tweets for #MITCEO

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users